A study of oxaliplatin-nucleobase interactions using ion trap electrospray mass spectrometry
Samantha L Kerr1, Tamer Shoeib, Barry L Sharp
1Department of Chemistry, Loughborough University, Loughborough, Leicestershire, LE11 3TU, UK.
Abstract:
Oxaliplatin is an important anti-cancer drug that has been approved for the treatment of colorectal cancer. It is known that oxaliplatin, like other Pt-based drugs, interacts with DNA to form cytotoxic Pt-DNA adducts that disrupt important biological processes such as DNA replication and protein synthesis. Linear ion trap electrospray ionisation mass spectrometry (ESI-MS) was employed to study the interaction of oxaliplatin with DNA nucleobases. It was shown that oxaliplatin formed adducts with all four DNA nucleobases when present individually and in combination in solution. Multiple-stage tandem mass spectrometry (MS(n)) enabled the fragmentation pathways of each adduct to be established. In addition, proposed structures for each product ion were obtained from the MS data. When all four bases were present together with the drug at near-equal molar concentrations, adducts containing predominantly adenine and guanine were formed, confirming that the drug preferentially binds to these nucleobases. A large molar excess of drug was required to ensure the formation of cytosine and thymine adducts in the presence of adenine and guanine. Even with a large excess of oxaliplatin, only mono-adducts of these nucleobases were observed when all four nucleobases were present.
Insights
Oxaliplatin, a colorectal cancer drug, forms adducts with all four DNA nucleobases. Mass spectrometry revealed preferential binding to adenine and guanine, requiring excess drug for cytosine and thymine adducts.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Molecular Biology
Background:
- Oxaliplatin is a platinum-based chemotherapy agent used for colorectal cancer.
- Platinum-based drugs exert cytotoxicity by forming DNA adducts, interfering with DNA replication and protein synthesis.
Purpose of the Study:
- To investigate the interaction of oxaliplatin with individual and combined DNA nucleobases.
- To characterize the adducts formed and determine the drug's binding preferences.
Main Methods:
- Linear ion trap electrospray ionization mass spectrometry (ESI-MS) was utilized.
- Multiple-stage tandem mass spectrometry (MS(n)) was employed for fragmentation analysis.
Main Results:
- Oxaliplatin formed adducts with all four DNA nucleobases (adenine, guanine, cytosine, and thymine) in solution.
- MS(n) elucidated fragmentation pathways and proposed structures for product ions.
- In the presence of all four bases, oxaliplatin preferentially formed adducts with adenine and guanine.
- Cytosine and thymine adducts required a large molar excess of oxaliplatin and were predominantly mono-adducts.
Conclusions:
- Oxaliplatin exhibits preferential binding to adenine and guanine over cytosine and thymine when all nucleobases are present.
- Understanding these binding preferences is crucial for elucidating oxaliplatin's mechanism of action and potential resistance mechanisms.
More Related Videos
07:33Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
Published on: October 15, 2018
07:45Technical Approach for Structural Analysis of an Unknown Compound in Huoxiang Zhengqi Oral Liquid based on Linear Ion Trap Mass Spectrometry
Published on: April 3, 2026
Related Concept Videos
Electrospray Ionization (ESI) Mass Spectrometry
ESI utilizes electrical energy to transfer ions from the liquid phase of the sample into the...
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences
Ion-Exchange Chromatography
Mass Analyzers: Common Types
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview
